Tecentriq Hybreza
Payments companies reported to CMS as associated with Tecentriq Hybreza. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Tecentriq Hybreza, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Tecentriq Hybreza
These are the largest totals companies reported as associated with Tecentriq Hybreza. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Todd Shenkenberg | Harlingen, TX | Hematology & Oncology | $156.61 |
| Ernesto Deleon | Harlingen, TX | Nurse Practitioner | $156.61 |
| Douglas Nelson | Louisville, KY | Medical Oncology | $150.00 |
| Jaspreet Grewal | Louisville, KY | Hematology & Oncology | $150.00 |
| Tracy Lemelle | Walker, LA | Pediatrics | $143.58 |
| Andrea Barrack | Kapolei, HI | Geriatric Medicine (Internal Medicine) | $143.58 |
| Dhruv Bansal | Overland Park, KS | Hematology & Oncology | $138.34 |
| Mark Harrison | Mcallen, TX | Radiation Oncology | $121.95 |
| Hirva Mamdani | Detroit, MI | Hematology & Oncology | $120.70 |
| Yiwu Huang | Brooklyn, NY | Hematology & Oncology | $119.36 |
Prescribed Tecentriq Hybreza?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.